PRVA
Undervalued by 63.9% based on the discounted cash flow analysis.
Market cap | $2.83 Billion |
---|---|
Enterprise Value | $2.45 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $0.12 |
Beta | 0.81 |
Outstanding Shares | 122,132,245 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 189.6 |
---|---|
PEG | -842.77 |
Price to Sales | 1.55 |
Price to Book Ratio | 3.88 |
Enterprise Value to Revenue | 1.29 |
Enterprise Value to EBIT | 103.11 |
Enterprise Value to Net Income | 164 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.02 |
No data
No data
Privia Health? is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...